LILRB3 and Autoimmunity: Our data demonstrated that LILRB3 engagement on primary human myeloid cells exerts potent immunoinhibitory functions and that LILRB3-specific mAbs are potentially powerful immunomodulatory agents, with broad applications ranging from transplantation to autoimmunity and beyond, where fine-tuning of immune responses through myeloid cell activity is desired.